Utilization of lung cancer cell lines for the study of lung cancer stem cells (Review)
- Authors:
- Yuyi Wang
- Ming Jiang
- Chi Du
- Yang Yu
- Yanyang Liu
- Mei Li
- Feng Luo
-
Affiliations: Department of Medical Oncology, Cancer Center, Lung Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, P.R. China - Published online on: March 14, 2018 https://doi.org/10.3892/ol.2018.8265
- Pages: 6791-6798
-
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Singh S and Chellappan S: Lung cancer stem cells: Molecular features and therapeutic targets. Mol Aspects Med. 39:50–60. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yan X, Luo H, Zhou X, Zhu B, Wang Y and Bian X: Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines. Oncol Rep. 30:2733–2740. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Akunuru S, Zhai James Q and Zheng Y: Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity. Cell Death Dis. 3:e3522012. View Article : Google Scholar : PubMed/NCBI | |
|
Meacham CE and Morrison SJ: Tumour heterogeneity and cancer cell plasticity. Nature. 501:328–337. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Dionne LK, Driver ER and Wang XJ: Head and neck cancer stem cells: From identification to tumor immune network. J Dent Res. 94:1524–1531. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Herzenberg LA, Parks D, Sahaf B, Perez O, Roederer M and Herzenberg LA: The history and future of the fluorescence activated cell sorter and flow cytometry: A view from Stanford. Clin Chem. 48:1819–1827. 2002.PubMed/NCBI | |
|
Xu Y, Zhao W, Wu D, Xu J, Lin S, Tang K, Yin Z and Wang X: Isolation of myeloid-derived suppressor cells subsets from spleens of orthotopic liver cancer-bearing mice by fluorescent-activated and magnetic-activated cell sorting: Similarities and differences. Int J Clin Exp Pathol. 7:7545–7553. 2014.PubMed/NCBI | |
|
Izumiya M, Kabashima A, Higuchi H, Igarashi T, Sakai G, Iizuka H, Nakamura S, Adachi M, Hamamoto Y, Funakoshi S, et al: Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells. Anticancer Res. 32:3847–3853. 2012.PubMed/NCBI | |
|
Vaughan MB, Ramirez RD, Wright WE, Minna JD and Shay JW: A three-dimensional model of differentiation of immortalized human bronchial epithelial cells. Differentiation. 74:141–148. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kucerova L, Feketeova L, Kozovska Z, Poturnajova M, Matuskova M, Nencka R and Babal P: In vivo 5FU-exposed human medullary thyroid carcinoma cells contain a chemoresistant CD133+ tumor-initiating cell subset. Thyroid. 24:520–532. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang A, Chen L, Pu K and Zhu Y: Identification of stem-like cells in non-small cell lung cancer cells with specific peptides. Cancer Lett. 351:100–107. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Schaefer-Prokop C, Prosch H and Prokop M: Lung cancer screening: What have we learnt for the practice so far? Radiologe. 54:462–469. 2014.(In German). View Article : Google Scholar : PubMed/NCBI | |
|
Spira A, Halmos B and Powell CA: Update in lung cancer 2014. Am J Respir Crit Care Med. 192:283–294. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Herbst RS, Heymach JV and Lippman SM: Lung cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Anglim PP, Alonzo TA and Laird-Offringa IA: DNA methylation-based biomarkers for early detection of non-small cell lung cancer: An update. Mol Cancer. 7:812008. View Article : Google Scholar : PubMed/NCBI | |
|
Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, et al: Non-small cell lung cancer, Version 6. 2015. J Natl Compr Canc Netw. 13:515–524. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kalemkerian GP, Akerley W, Bogner P, Borghaei Hossein, Chow LQ, Downey RJ, Gandhi L, Ganti P AK, Govindan R, Grecula JC, et al: Small cell lung cancer. J Natl Compr Canc Netw. 11:78–98. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Alison MR, Lin WR, Lim SM and Nicholson LJ: Cancer stem cells: In the line of fire. Cancer Treat Rev. 38:589–598. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bonnet D and Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Giangreco A, Arwert EN, Rosewell IR, Snyder J, Watt FM and Stripp BR: Stem cells are dispensable for lung homeostasis but restore airways after injury. Proc Natl Acad Sci USA. 106:9286–9291. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL and Rich JN: Cancer stem cells in glioblastoma. Genes Dev. 29:1203–1217. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Gawlik-Rzemieniewska N and Bednarek I: The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells. Cancer Biol Ther. 17:1–10. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Fulawka L, Donizy P and Halon A: Cancer stem cells-the current status of an old concept: Literature review and clinical approaches. Biol Res. 47:662014. View Article : Google Scholar : PubMed/NCBI | |
|
Ucar D, Cogle CR, Zucali JR, Ostmark B, Scott EW, Zori R, Gray BA and Moreb JS: Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem Biol Interact. 178:48–55. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tirino V, Camerlingo R, Bifulco K, Irollo E, Montella R, Paino F, Sessa G, Carriero MV, Normanno N, Rocco G and Pirozzi G: TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction. Cell Death Dis. 4:e6202013. View Article : Google Scholar : PubMed/NCBI | |
|
Ahmadipour F, Noordin MI, Mohan S, Arya A, Paydar M, Looi CY, Keong YS, Siyamak EN, Fani S, Firoozi M, et al: Koenimbin, a natural dietary compound of murraya koenigii (L) spreng: Inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24 (-/low)): An in vitro study. Drug Des Devel Ther. 9:1193–1208. 2015.PubMed/NCBI | |
|
Chang Y, Zhao Y, Gu W, Cao Y, Wang S, Pang J and Shi Y: Bufalin inhibits the differentiation and proliferation of cancer stem cells derived from primary osteosarcoma cells through Mir-148a. Cell Physiol Biochem. 36:1186–1196. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Keysar SB and Jimeno A: More than markers: Biological significance of cancer stem cell-defining molecules. Mol Cancer Ther. 9:2450–2457. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
White A and Swanson SJ: Minimally invasive surgery for early-stage lung cancer: From innovation to standard of care. Oncology (Williston Park). 30:982–987. 2016.PubMed/NCBI | |
|
Gazdar AF, Girard L, Lockwood WW, Lam WL and Minna JD: Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst. 102:1310–1321. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Damhofer H, Ebbing EA, Steins A, Welling L, Tol JA, Krishnadath KK, van Leusden T, van de Vijver MJ, Besselink MG, Busch OR, et al: Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract. J Transl Med. 13:1152015. View Article : Google Scholar : PubMed/NCBI | |
|
Rubin H: Multistage carcinogenesis in cell culture. Dev Biol (Basel). 106(61–67): 143–160. 2001. | |
|
Jones MF, Hara T, Francis P, Li XL, Bilke S, Zhu Y, Pineda M, Subramanian M, Bodmer WF and Lal A: The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation. Proc Natl Acad Sci USA. 112:E1550–E1558. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wang K, Zeng J, Luo L, Yang J, Chen J, Li B and Shen K: Identification of a cancer stem cell-like side population in the HeLa human cervical carcinoma cell line. Oncol Lett. 6:1673–1680. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Van den Broeck A, Vankelecom H, Van Delm W, Gremeaux L, Wouters J, Allemeersch J, Govaere O, Roskams T and Topal B: Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes. PLoS One. 8:e739682013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Chen D, Yang S, Ma R, Pan Y, Li X and Ma S: Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients. Cancer Cell Int. 15:432015. View Article : Google Scholar : PubMed/NCBI | |
|
Goodell MA, Brose K, Paradis G, Conner AS and Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Salcido CD, Larochelle A, Taylor BJ, Dunbar CE and Varticovski L: Molecular characterization of side population cells with cancer stem cell-like characteristics in small-cell lung cancer. Br J Cancer. 102:1636–1644. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wu C and Alman BA: Side population cells in human cancers. Cancer Lett. 268:1–9. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA and Katz RL: Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J, Xiao Z, Wong SK, Tin VP, Ho KY, Wang J, Sham MH and Wong MP: Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells. Oncotarget. 4:1698–1711. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Okudela K, Woo T, Mitsui H, Suzuki T, Tajiri M, Sakuma Y, Miyagi Y, Tateishi Y, Umeda S, Masuda M and Ohashi K: Downregulation of ALDH1A1 expression in non-small cell lung carcinomas-its clinicopathologic and biological significance. Int J Clin Exp Pathol. 6:1–12. 2013.PubMed/NCBI | |
|
Meng X, Wang X and Wang Y: More than 45% of A549 and H446 cells are cancer initiating cells: Evidence from cloning and tumorigenic analyses. Oncol Rep. 21:995–1000. 2009.PubMed/NCBI | |
|
Willerson JT: CD133+ stem cells in the treatment of patients with refractory angina. Circ Res. 120:602–603. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yi H, Cho HJ, Cho SM, Jo K, Park JA, Lee SH, Chang BJ, Kim JS and Shin HC: Effect of 5-FU and MTX on the expression of drug-resistance related cancer stem cell markers in non-small cell lung cancer cells. Korean J Physiol Pharmacol. 16:11–16. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang HZ, Lin XG, Hua P, Wang M, Ao X, Xiong LH, Wu C and Guo JJ: The study of the tumor stem cell properties of CD133+CD44+ cells in the human lung adenocarcinoma cell lineA549. Cell Mol Biol (Noisy-le-grand). 56 Suppl:OL1350–OL1358. 2010.PubMed/NCBI | |
|
Roudi R, Madjd Z, Ebrahimi M, Samani FS and Samadikuchaksaraei A: CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549. Cell Mol Biol Lett. 19:23–36. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Nakatsugawa M, Takahashi A, Hirohashi Y, Torigoe T, Inoda S, Murase M, Asanuma H, Tamura Y, Morita R, Michifuri Y, et al: SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity. Lab Invest. 91:1796–1804. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sung JM, Cho HJ, Yi H, Lee CH, Kim HS, Kim DK, Abd El-Aty AM, Kim JS, Landowski CP, Hediger MA and Shin HC: Characterization of a stem cell population in lung cancer A549 cells. Biochem Biophys Res Commun. 371:163–167. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Curry JM, Sprandio J, Cognetti D, Luginbuhl A, Bar-ad V, Pribitkin E and Tuluc M: Tumor microenvironment in head and neck squamous cell carcinoma. Semin Oncol. 41:217–234. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kondo T: Stem cell-like cancer cells in cancer cell lines. Cancer Biomark. 3:245–250. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Sääf AM, Halbleib JM, Chen X, Yuen ST, Leung SY, Nelson WJ and Brown PO: Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and coloncancer. Mol Biol Cell. 18:4245–4260. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K and Los M: Cancer stem cell markers in common cancers-therapeutic implications. Trends Mol Med. 14:450–460. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, Sihoe AD, Fink LM, Ma Y and Wong MP: Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One. 5:e140622010. View Article : Google Scholar : PubMed/NCBI | |
|
Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo JV, Chomienne C, Ishikawa F, Schuringa JJ, Stassi G, et al: Cancer stem cell definitions and terminology: The devil is in the details. Nat Rev Cancer. 12:767–775. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lin WC, Rajbhandari N and Wagner KU: Cancer cell dormancy in novel mouse models for reversible pancreatic cancer: A lingering challenge in the development of targeted therapies. Cancer Res. 74:2138–2143. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Williams AB: Spontaneous mutation rates come into focus in Escherichia coli. DNA Repair (Amst). 24:73–79. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Le Beyec J, Xu R, Lee SY, Nelson CM, Rizki A, Alcaraz J and Bissell MJ: Cell shape regulates global histone acetylation in human mammary epithelial cells. Exp Cell Res. 313:3066–3075. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Gazdar AF, Gao B and Minna JD: Lung cancer cell lines: Useless artifacts or invaluable tools for medicine science? Lung Cancer. 68:309–318. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Roschke AV, Tonon G, Gehlhaus KS, McTyre N, Bussey KJ, Lababidi S, Scudiero DA, Weinstein JN and Kirsch IR: Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res. 63:8634–8647. 2003.PubMed/NCBI | |
|
Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, Yung R, Parmigiani G, Dorsch M, Peacock CD and Watkins DN: A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res. 69:3364–3373. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Gazdar AF, Bader S, Hung J, Kishimoto Y, Sekido Y, Sugio K, Virmani A, Fleming J, Carbone DP and Minna JD: Molecular genetic changes found in human lung cancer and its precursor lesions. Cold Spring Harb Symp Quant Biol. 59:565–572. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Akunuru S, Zhai James Q and Zheng Y: Non-small cell lung cncer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity. Cell Death Dis. 3:e3522012. View Article : Google Scholar : PubMed/NCBI | |
|
Shultz LD, Ishikawa F and Greiner DL: Humanized mice in translational biomedical research. Nature Rev Immunol. 7:118–130. 2007. View Article : Google Scholar | |
|
Perumal D, Singh S, Yoder SJ, Bloom GC and Chellappan SP: A novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLC. PLoS One. 7:e435892012. View Article : Google Scholar : PubMed/NCBI | |
|
Yeh CT, Su CL, Huang CY, Lin JK, Lee WH, Chang PM, Kuo YL, Liu YW, Wang LS, Wu CH, et al: A preclinical evaluation of antimycin a as a potential antilung cancer stem cell agent. Evid Based Complement Alternat Med. 2013:9104512013. View Article : Google Scholar : PubMed/NCBI | |
|
Ho MM, Ng AV, Lam S and Hung JY: Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J and Mao Z, Huang J, Xie S, Liu T and Mao Z: Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy. Biochem Biophys Res Commun. 444:670–675. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Y, Jiang Z, Zhang Z, Sun N, Zhang M, Xie J, Li T, Hou Y and Wu D: HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties. J Cell Biochem. 115:1112–1121. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, et al: Highly tumorigenic lung cancer CD133+ cells exhibit stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA. 106:16281–16286. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Yao Q, Sun JG, Ma H, Zhang AM, Lin S, Zhu CH, Zhang T and Chen ZT: Monitoring microRNAs using a molecular beacon in CD133+/CD338+ human lung adenocarcinoma-initiating A549cells. Asian Pac J Cancer Prev. 15:161–166. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lin S, Sun JG, Wu JB, Long HX, Zhu CH, Xiang T, Ma H, Zhao ZQ, Yao Q, Zhang AM, et al: Aberrant microRNAs expression in CD133+/CD326+ human lung adenocarcinoma initiating cells from A549. Mol Cells. 33:277–283. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Xiang Y, Xiang L, Xiao Y, Li F and Hao P: ALDH maintains the stemness of lung adenoma stem cells by suppressing the notch/CDK2/CCNE pathway. PLoS One. 9:e926692014. View Article : Google Scholar : PubMed/NCBI | |
|
Kim IG, Kim SY, Choi SI, Lee JH, Kim KC and Cho EW: Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling. Oncogene. 33:3908–3917. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zakaria N, Yusoff NM, Zakaria Z, Lim MN, Baharuddin PJ, Fakiruddin KS and Yahaya B: Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells. BMC Cancer. 15:842015. View Article : Google Scholar : PubMed/NCBI | |
|
Ghosh G, Lian X, Kron SJ and Palecek SP: Properties of resistant cells generated from lung cancer cell lines treated with EGFR inhibitors. BMC Cancer. 12:952012. View Article : Google Scholar : PubMed/NCBI | |
|
Levina V, Marrangoni AM, DeMarco R, Gorelik E and Lokshin AE: Drug-selected human lung cancer stem cells: Cytokine network, tumorigenic and metastatic properties. PLoS One. 3:e30772008. View Article : Google Scholar : PubMed/NCBI | |
|
Shi Y, Fu X, Hua Y, Han Y, Lu Y and Wang J: The side population in human lung cancer cell line NCI-H460 is enriched in stem-like cancer cells. PLoS One. 7:e333582012. View Article : Google Scholar : PubMed/NCBI | |
|
Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, Lai TC, Lee CH, Hsiao YW, Lu J, et al: Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. Cancer Res. 73:406–416. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shien K, Toyooka S, Yamamoto H, Soh J, Jida M, Thu KL, Hashida S, Maki Y, Ichihara E, Asano H, et al: Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells. Cancer Res. 73:3051–3061. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Jaggupilli A and Elkor E: Significance of CD44 and CD24 as cancer stem cell markers: An enduring ambiguity. Clin Dev Immunol. 2012:7080362012. View Article : Google Scholar : PubMed/NCBI | |
|
Teng Y, Wang X, Wang Y and Ma D: Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells. Biochem Biophys Res Commun. 392:373–379. 2010. View Article : Google Scholar : PubMed/NCBI |
